“PHARMACOLOGIC TOPOISOMERASE-I INHIBITION CAUSES DNA DAMAGE AND MORTALITY IN ACTIVATED CD4+ T CELLS”. Genetics & Applications 2, no. 2 (December 25, 2018): 51–56. Accessed November 14, 2026. https://genapp.ba/editions/index.php/journal/article/view/108.